Magnetic resonance imaging and spectroscopy

Handbook of Experimental Pharmacology

Volumn 185, Issue PART1, 2008, Pages 75-90

  Schaeffter, Tobias ^a   Dahnke, Hannes ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b PHILIPS RESEARCH LABORATORIES   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ANIMAL; EQUIPMENT DESIGN; HUMAN; INSTRUMENTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REVIEW; SENSITIVITY AND SPECIFICITY; THEORETICAL MODEL;

ANIMALS; CONTRAST MEDIA; EQUIPMENT DESIGN; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, THEORETICAL; SENSITIVITY AND SPECIFICITY;

EID: 52049104684     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-540-72718-7_4     Document Type: Article

References (36)

1. Abraham RJ, Fisher J, Loftus P (1988) Introduction to NMR spectroscopy. Wiley
2. Chichester Albert MS, Cates GD, Driehuys B et al (1994) Biological magnetic resonance imaging using laserpolarized 129Xe. Nature 370:199-201
3. Avison MJ, Hetherington HP, Shulman RG (1986) Applications of NMR to studies of tissue metabolism. Annu Rev Biophys Biophys Chem 15:377-402
4. Bloch F, Hansen WW, Packard ME (1946) Nuclear induction. Phys Rev 69:127
5. Bloembergen N, Purcell EM, Pound RV (1948) Relaxation effects in nuclear magnetic resonance absorption. Phys Rev 73:679-712
6. Dahnke H, Schaeffter T (2005) Limits of detection of SPIO at 3.0 T using T2 relaxometry. Magn Reson Med 53(5):1202-1206
7. Ernst T, Hennig J (1994) Observation of a fast response in functional MR. Magn Reson Med 32(1):146-149
8. Evanochko WT, Ng TC, Glickson JD (1984) Application of in vivo NMR spectroscopy to cancer. Magn Reson Med 1(4):508-534
9. Golman K, Axelsson O, Johannesson H et al (2001) Parahydrogen-induced polarization in imaging: subsecond (13)C angiography. Magn Reson Med 46(1):1-5
10. Golman K, Olsson LE, Axelsson O et al (2003) Molecular imaging using hyperpolarized 13C. Br J Radiol 76(2):118-127
11. Haacke EM, Brown RW, Thomson MR et al (1999) Magnetic resonance imaging, physical principles and sequence design. Wiley-Liss, New York
12. Heyn C, Bowen CV, Rutt BK et al (2005) Detection threshold of single SPIO-labeled cells with FIESTA.Magn Reson Med 53(2):312-320
13. Hoult DI (1979) Rotating frame zeugmatography. J Magn Reson 33:183-197
14. Lanza GM, Wallace KD, Scott MJ et al (1996) A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 95:3334-3340
15. Lanza GM, Yu X, Winter PM et al (2002) Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis. Circulation 106(22):2842-2847
16. Lawaczeck R, Bauer H, Frenzel T et al (1997) Magnetic iron oxide particles coated with carboxydextran for parenteral administration and liver contrasting. Pre-clinical profile of SH U555A. Acta Radiol 38(4):584-597
17. Macovski A (1996). Noise in MRI. Magn Reson Med 36(3):494-497
18. Mehta RC, Pike GB, Enzmann DR (1996) Magnetization transfer magnetic resonance imaging: a clinical review. Top Magn Reson Imaging 8(4):214-230
19. Mikawa M, Kato H, Okumura Met al (2001) Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents. Bioconjug Chem 12:510-514
20. Moller HE, Chen XJ, Saam B et al (2002) MRI of the lungs using hyperpolarized noble gases. Magn Reson Med 47(6):1029-1051
21. Moon RB, Richards JH (1973) Determination of Intracellular pH by 31P Magnetic Resonance. J Biol Chem 248:7276-7278
22. Moonen CTW, Bandettini PA (1999) Functional MRI. Springer, Berlin Heidelberg New York
23. Morawski AM,Winter PM, Crowder KC et al (2004) Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI. Magn Reson Med 51(3):480-486
24. Ogawa S, Lee TM, Kay AR et al (1990). Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci USA 87(24):9868-9872
25. Ordige RJ, Bendall MR, Gordon RE et al (1985) Volume selection for in-vivo biological spectroscopy. In: Govil G, Khetrapal CL, Saran A (eds) Magnetic resonance in biology and medicine. Tata McGraw Hill, New Delhi, pp 387-397
26. Presant CA,Wolf W,Waluch V et al (1994) Association of intratumoral pharmacokinetics of fluorouracil with clinical response. Lancet 343(8907):1184-1187
27. Prichard JW, Shulman RG (1986) NMR spectroscopy of brain metabolism in vivo. Annu Rev Neurosci 9:61-85
28. Pruessmann KP, Weiger M, Scheidegger MB et al (1999) SENSE: sensitivity encoding for fast MRI. Magn Reson Med 42(5):952-962
29. Purcell EM, Torrey HC, Pound RV (1946) Resonance absorption by nuclear magnetic moments in a solid. Phys Rev 69:37-38
30. Schuhmann-Giampieri G, Schmitt-Willich H, Frenzel T (1991) In vivo and in vitro evaluation of Gd-DTPA-polylysine as a macromolecular contrast agent for magnetic resonance imaging. Invest Radiol 26:969-974
31. Speck O, Hennig J (1998) Functional imaging by I0-and T?2-parameter mapping using multi-image EPI. J Magn Reson Med 40(2):243-248
32. Toth E, Helm L, Merbach AE (2001) Relaxivity of gadolinium(III) complexes: theory and mechanism. In: Toth E, Merbach AE (eds) The chemistry of contrast agents in medical magnetic resonance imaging. Wiley, New York
33. Unger E, Shen DK, Wu GL et al (1991) Liposomes as MR contrast agents: pros and cons. Magn Reson Med 22:304-308
34. Vlaardingerbroek MT, den Boer JA (2002) Magnetic resonance imaging, theory and practice, 3rd edn. Springer, Berlin Heidelberg New York
35. Wang YX, Hussain SM, Krestin GP (2001) Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 11(11):2319-2331
36. Wiener EC, Brechbiel MW, Brothers H et al (1994) Dendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agents. Magn Reson Med 31:1-8